CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for RenovaCare Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

RenovaCare Inc
9375 E. Shea Blvd., Suite 107-A
Phone: (800) 755-5815p:800 755-5815 SCOTTSDALE, AZ  85260  United States Ticker: RCARRCAR
Business Summary
RenovaCare, Inc. is a clinical-stage biotechnology company. The Company is focused on developing autologous (self-donated) stem cell therapies for the regeneration of human organs. The Company through its wholly owned subsidiary, RenovaCare Sciences Corp. is focusing on the research, development and commercialization of autologous (using a patient’s own cells) cellular therapies that can be used for medical and aesthetic applications. The Company’s CellMist System is a cell isolation procedure that enzymatically renders stem cells from the patient’s own skin or other tissues. The resulting stem cell suspension is administered topically from the Company’s novel solution sprayer device (the SkinGun) as a cell therapy for wounds including burns to facilitate healing. Its SkinGun spray device is an advanced technology, using a gentle positive-pressure air stream to spray the CellMist Solution onto wounds.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202212/31/2021YesYes---

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
2836 Biological products, except diagnostic substances
3842 Orthopedic, prosthetic, and surgical appliances and supplies
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Interim President, Chief Executive Officer, Interim Chief Financial Officer, Harmel S.Rayat 62 3/24/2022 3/18/1996
CFO JUSTIN .FRERE
Chief Scientific Officer Robin A.Robinson 66 5/26/2020 8/20/2019

Business Names
Business Name
ENTHEOS TECHNOLOGIES INC
Entheos Technologies Inc.
ETHT
ETNI
RCAR
RenovaCare Sciences Corp.

General Information
Number of Employees: 1 (As of 12/31/2021)
Outstanding Shares: 87,352,364 (As of 11/10/2022)
Shareholders: 362
Stock Exchange: OTC
Federal Tax Id: 980170247


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024